Key result
Adjuvant hyperbaric oxygen therapy successfully treated 86% (12 of 14) of hardware-related infection events in neuromodulation without the need for hardware removal.
Why the study?
Does adjuvant hyperbaric oxygen therapy improve infection resolution and prevent hardware removal in patients with neuromodulation hardware-related infections?
Observational (n=12)
No
Does adjuvant hyperbaric oxygen therapy improve infection resolution and prevent hardware removal in patients with neuromodulation hardware-related infections?
Adjuvant hyperbaric oxygen therapy may help resolve hardware-related infections in neuromodulation without requiring hardware removal, though device compatibility must be monitored.
May spare hardware explantation in neuromodulation infections; leaves open efficacy pending prospective trials.
BACKGROUND: In neuromodulation therapies, hardware-related infections are a major challenge often leading to hardware removal. OBJECTIVE: To investigate the role of adjuvant hyperbaric oxygen therapy (HBOT) in hardware-related infections. METHODS: Fourteen hardware-related infection events in 12 consecutive patients between 2002 and 2015 were treated with antibiotics and adjuvant HBOT at the Karolinska University Hospital (Stockholm, Sweden). Two time-independent infection events related to hardware replacements occurred in 2 patients. Infection resolution and the need for hardware removal were assessed. RESULTS: Twelve out of 14 events of hardware-related infection were successfully treated without hardware removal (86%). The 2 patients treated twice with HBOT on 2 time-independent occasions could retain their hardware in both cases. Hardware was removed following HBOT failure in 2 infection events, with long-term infection control achieved in all patients. Further, an intrathecal pump malfunction caused by HBOT at 2.8 bars was observed, leading to a change in the manufacturer's guidelines. CONCLUSIONS: This study indicates a potential benefit of adjuvant HBOT in the treatment of hardware-related infections in neuromodulation, diminishing the need for hardware removal and treatment interruption. Prospective studies are warranted to establish the role of adjuvant HBOT in the treatment of hardware-related infections in neuromodulation.
No takes yet. Share an insight, caveat, or question.
Bártek et al. (2018) conducted an observational in Hardware-related infections in neuromodulation (n=12). Adjuvant hyperbaric oxygen therapy (HBOT) was evaluated on Infection resolution and the need for hardware removal. Adjuvant hyperbaric oxygen therapy successfully treated 86% (12 of 14) of hardware-related infection events in neuromodulation without the need for hardware removal.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: